Turbine

Turbine is a private European biotechnology company developing a simulation-based, scalable drug discovery platform. The Simulated Cell™ unlocks novel therapies for high unmet oncology needs which the team aims to take through to clinical proof-of-concept and beyond. The technology has been validated in numerous collaborations with pharmaceutical companies, including Bayer. Since being founded in 2015 by bioengineer Kristof Szalay, cancer researcher Daniel Veres, and deep tech entrepreneur Szabolcs Nagy, Turbine has raised EUR 9 million through Seed and pre-Series A rounds from international investors in the USA and Europe including Accel, XTX Ventures, Boston Millenia Partners, Delin Ventures, Atlantic Labs and o2h Ventures. In 2019, the company was selected for EITH's highly competitive mentoring program, Gold Track.